Carerx Stock Price Prediction
| CHHHF Stock | USD 1.40 0.00 0.00% |
Oversold Vs Overbought
19
Oversold | Overbought |
Using CareRx hype-based prediction, you can estimate the value of CareRx from the perspective of CareRx response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in CareRx to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying CareRx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
CareRx after-hype prediction price | USD 1.4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
CareRx |
CareRx After-Hype Price Prediction Density Analysis
As far as predicting the price of CareRx at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in CareRx or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of CareRx, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
CareRx Estimiated After-Hype Price Volatility
In the context of predicting CareRx's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on CareRx's historical news coverage. CareRx's after-hype downside and upside margins for the prediction period are 0.07 and 4.00, respectively. We have considered CareRx's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
CareRx is very risky at this time. Analysis and calculation of next after-hype price of CareRx is based on 3 months time horizon.
CareRx Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as CareRx is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CareRx backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with CareRx, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 2.60 | 0.00 | 0.01 | 0 Events / Month | 3 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.40 | 1.40 | 0.00 |
|
CareRx Hype Timeline
CareRx is currently traded for 1.40. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. CareRx is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.16%. %. The volatility of related hype on CareRx is about 3611.11%, with the expected price after the next announcement by competition of 1.41. About 30.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.78. Some equities with similar Price to Book (P/B) outperform the market in the long run. CareRx recorded a loss per share of 0.38. The entity last dividend was issued on the 25th of June 2020. The firm had 1:20 split on the 25th of June 2020. Assuming the 90 days horizon the next forecasted press release will be in 5 to 10 days. Check out CareRx Basic Forecasting Models to cross-verify your projections.CareRx Related Hype Analysis
Having access to credible news sources related to CareRx's direct competition is more important than ever and may enhance your ability to predict CareRx's future price movements. Getting to know how CareRx's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how CareRx may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BCBCF | The BC Bud | 0.00 | 0 per month | 3.95 | 0.18 | 31.93 | (10.36) | 425.33 | |
| AXRX | Amexdrug | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NNRX | Nutranomics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ANTCF | Aion Therapeutic | 0.00 | 0 per month | 19.69 | 0.17 | 84.21 | (60.00) | 508.95 | |
| MNFSF | ManifestSeven Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SNDL | SNDL Inc | (0.01) | 8 per month | 0.00 | (0.01) | 4.17 | (3.60) | 24.46 | |
| SHPH | Shuttle Pharmaceuticals | (0.22) | 5 per month | 0.00 | (0.02) | 11.48 | (8.82) | 50.96 | |
| ACB | Aurora Cannabis | (0.17) | 11 per month | 0.00 | (0.04) | 5.30 | (4.75) | 26.91 | |
| TEVA | Teva Pharma Industries | 0.75 | 10 per month | 1.76 | 0.08 | 3.66 | (2.75) | 29.83 | |
| ELAN | Elanco Animal Health | 0.37 | 8 per month | 0.00 | (0.11) | 2.45 | (3.89) | 20.17 |
CareRx Additional Predictive Modules
Most predictive techniques to examine CareRx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for CareRx using various technical indicators. When you analyze CareRx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About CareRx Predictive Indicators
The successful prediction of CareRx stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as CareRx, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of CareRx based on analysis of CareRx hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to CareRx's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to CareRx's related companies.
Story Coverage note for CareRx
The number of cover stories for CareRx depends on current market conditions and CareRx's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that CareRx is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about CareRx's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
CareRx Short Properties
CareRx's future price predictability will typically decrease when CareRx's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of CareRx often depends not only on the future outlook of the potential CareRx's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CareRx's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 46.3 M |
Complementary Tools for CareRx Pink Sheet analysis
When running CareRx's price analysis, check to measure CareRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CareRx is operating at the current time. Most of CareRx's value examination focuses on studying past and present price action to predict the probability of CareRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CareRx's price. Additionally, you may evaluate how the addition of CareRx to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world |